ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 261726 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 261726; 2) Community: the network communities that were significantly associated with the response to NSC 261726; 3) Molecule: the relationships between components within communities and NSC 261726; 4) MDR: the compounds that were significantly associated with the NSC 261726.

NSC Compound Enrichment Correlation
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.00216000169440201 0.29262334
NSC 610459 Camptothecin Derivative 0.00216000169440201 0.23772393
NSC 638441 Null 0.00216000169440201 0.20041816
NSC 639186 Raltitrexed 0.00216000169440201 0.15770065
NSC 704639 Null 0.00216000169440201 0.35471426
NSC 708446 Null 0.00216000169440201 0.27977304
NSC 88903 Null 0.00216000169440201 0.086248929
NSC 712735 Null 0.002272386738769 0.38550972
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.00293992674122322 0.47432506
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.00293992674122322 0.32256736
Total:73  Current:7    [First] [Prev] [Next] [Last]